Upscaling the Use of Fallout Radionuclides in Soil Erosion and Sediment Budget Investigations: Addressing the Challenge

AbstractThe application of fallout radionuclides in soil erosion investigations and related sediment budget studies has provided a widely used tool for improving understanding of soil erosion and sediment transfer processes. However, most studies using fallout radionuclides undertaken to date have focussed on small areas. This focus on small areas reflects both the issues addressed and practical constraints associated with sample collection and analysis. Increasing acceptance of the important role of fine sediment in degrading aquatic habitats and in the transfer and fate of nutrients and contaminants within terrestrial and fluvial systems has emphasised the need to consider larger areas and the catchment or regional scale. The need to upscale existing approaches to the use of fallout radionuclides to larger areas represents an important challenge. This contribution provides a brief review of existing and potential approaches to upscaling the use of fallout radionuclides and presents two examples where such approaches have been successfully applied. These involve a national scale assessment of soil erosion rates in England and Wales based on 137Cs measurements and an investigation of the sediment budgets of three small/intermediate-size catchments in southern Italy

Epstein-Barr virus: clinical and epidemiological revisits and genetic basis of oncogenesis

Epstein-Barr virus (EBV) is classified as a member in the order herpesvirales, family herpesviridae, subfamily gammaherpesvirinae and the genus lymphocytovirus. The virus is an exclusively human pathogen and thus also termed as human herpesvirus 4 (HHV4). It was the first oncogenic virus recognized and has been incriminated in the causation of tumors of both lymphatic and epithelial nature. It was reported in some previous studies that 95% of the population worldwide are serologically positive to the virus. Clinically, EBV primary infection is almost silent, persisting as a life-long asymptomatic latent infection in B cells although it may be responsible for a transient clinical syndrome called infectious mononucleosis. Following reactivation of the virus from latency due to immunocompromised status, EBV was found to be associated with several tumors. EBV linked to oncogenesis as detected in lymphoid tumors such as Burkitt's lymphoma (BL), Hodgkin's disease (HD), post-transplant lymphoproliferative disorders (PTLD) and T-cell lymphomas (e.g. Peripheral T-cell lymphomas; PTCL and Anaplastic large cell lymphomas; ALCL). It is also linked to epithelial tumors such as nasopharyngeal carcinoma (NPC), gastric carcinomas and oral hairy leukoplakia (OHL). In vitro, EBV many studies have demonstrated its ability to transform B cells into lymphoblastoid cell lines (LCLs). Despite these malignancies showing different clinical and epidemiological patterns when studied, genetic studies have suggested that these EBV- associated transformations were characterized generally by low level of virus gene expression with only the latent virus proteins (LVPs) upregulated in both tumors and LCLs. In this review, we summarize some clinical and epidemiological features of EBV- associated tumors. We also discuss how EBV latent genes may lead to oncogenesis in the different clinical malignancie